Jane Street Group, LLC Dexcom Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 18,749 shares of DXCM stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,749

Previous 176,761 89.39%

Holding current value

$1.46 Million

Previous $20 Million 93.73%

% of portfolio

0.0%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $10.1 Million - $18.3 Million	-158,012 Reduced 89.39%	18,749 $1.26 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $83.3 Million - $106 Million	-755,076 Reduced 81.03%	176,761 $20 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $55.4 Million - $68 Million	485,090 Added 108.58%	931,837 $129 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $22.3 Million - $36.7 Million	295,509 Added 195.39%	446,747 $55.4 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $1.78 Million - $2.85 Million	-20,633 Reduced 12.0%	151,238 $14.1 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $15.4 Million - $18 Million	137,072 Added 393.9%	171,871 $22.1 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $15.4 Million - $18.2 Million	-148,313 Reduced 81.0%	34,799 $4.04 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $6.11 Million - $8.82 Million	-71,920 Reduced 28.2%	183,112 $20.7 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $5.34 Million - $6.58 Million	69,896 Added 37.75%	255,032 $20.5 Million
Q2 2022 Aug 16, 2022	BUY	$67.99 - $132.89 $7.99 Million - $15.6 Million	117,489 Added 173.68%	185,136 $13.8 Million
Q1 2022 May 17, 2022	BUY	$94.08 - $130.2 $3.12 Million - $4.32 Million	33,203 Added 96.4%	67,647 $34.6 Million
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $1.52 Million - $1.91 Million	11,720 Added 51.58%	34,444 $18.5 Million
Q3 2021 Nov 16, 2021	SELL	$106.71 - $143.18 $1.35 Million - $1.81 Million	-12,650 Reduced 35.76%	22,724 $12.4 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $849,423 - $1.13 Million	10,488 Added 42.14%	35,374 $15.1 Million
Q1 2021 May 18, 2021	BUY	$84.79 - $104.74 $524,850 - $648,340	6,190 Added 33.11%	24,886 $8.94 Million
Q4 2020 Feb 17, 2021	BUY	$78.0 - $104.5 $798,174 - $1.07 Million	10,233 Added 120.91%	18,696 $6.91 Million
Q3 2020 Nov 17, 2020	SELL	$95.51 - $112.95 $5.17 Million - $6.11 Million	-54,126 Reduced 86.48%	8,463 $3.49 Million
Q2 2020 Aug 17, 2020	BUY	$62.68 - $105.34 $3.6 Million - $6.06 Million	57,512 Added 1132.79%	62,589 $25.4 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $40,573 - $64,209	-849 Reduced 14.33%	5,077 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $203,241 - $317,959	-5,550 Reduced 48.36%	5,926 $1.3 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $255,922 - $315,491	-7,203 Reduced 38.56%	11,476 $1.71 Million
Q1 2019 May 16, 2019	BUY	$28.07 - $38.18 $291,928 - $397,072	10,400 Added 125.62%	18,679 $2.23 Million
Q4 2018 Feb 15, 2019	SELL	$26.99 - $37.37 $139,052 - $192,530	-5,152 Reduced 38.36%	8,279 $992,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $242,746 - $381,741	10,396 Added 342.54%	13,431 $1.92 Million
Q2 2018 Aug 15, 2018	SELL	$17.54 - $25.22 $26,011 - $37,401	-1,483 Reduced 32.82%	3,035 $288,000
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $482,645 - $685,164	-36,956 Reduced 89.11%	4,518 $335,000
Q4 2017 Feb 15, 2018	BUY	$11.12 - $15.38 $265,067 - $366,613	23,837 Added 135.15%	41,474 $2.38 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $200,356 - $334,750	17,637	17,637 $863,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Dexcom Inc Transaction History